Cardiovascular event costs in patients with Type 2 diabetes mellitus.

CONCLUSIONS: These results illustrate the potential clinical and economic importance of considering patients' CVD risk and medications' cardiovascular safety profile when treating T2DM patients.
PMID: 26189723 [PubMed - in process]

Source: Journal of Medical Economics - February 13, 2016 Category: Health Management Tags: J Med Econ Source Type: research